drugset
drugset / Trial / NCT04292171

Gabapentin for Perioperative Pain Relief in Surgical Abortion

NCT04292171 ↗

Phase 0 Completed 219 enrolled University of Nevada, Las Vegas
RandomizedParallel-groupTriple-blindTreatment

Summary

Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.

Timeline

Start
2017-05-01
Primary completion
2018-03-30
Completion
2018-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 600 mg —

Indications

No indication recorded.